Skip to content
Cover: a nurse measuring an older man's blood pressure in a clinic

Hypertensive kidney damage: any regeneration plan starts with blood pressure

Why pressure control outperforms expensive alternatives

Quick answer

Chronic hypertension thickens and narrows renal vessels, reducing perfusion until tissue atrophies and scars. Outcomes improve most when pressure is brought to target alongside sodium restriction and kidney-protective drugs. Stem cell infusion is investigational and must not replace pressure control.

Key facts

Damage mechanism
Vascular narrowing and ischaemia
Better measurement
Home BP monitoring
Immediate lever
Reduce sodium
Renal-protective drugs
ACEi/ARB
Cell therapy role
Investigational only

Many patients only measure blood pressure at the clinic, which misleads. Home readings morning and evening, logged for the doctor, reveal the real picture and often change the drug plan immediately at no extra cost.

Sodium is the lever you control today. Many Thai and Korean dishes carry more sodium than expected, and cutting dipping sauces, soups and pickles often lowers pressure as much as adding a drug.

Research explores cell therapy for fibrosis from chronic ischaemia, but if pressure stays high the driver keeps working and any potential benefit is erased before long.

Frequently asked questions

  • What is the BP target?

    It is individualised; kidney patients with proteinuria usually get a stricter target.

  • Do BP drugs harm the kidney?

    ACEi/ARB can nudge creatinine slightly at first, which is expected, while protecting the kidney long term.

  • What exercise suits me?

    Brisk walking, light cycling or swimming regularly; avoid very heavy lifting without medical advice.

  • Can I stop drugs once BP normalises?

    No — normal readings are usually the drug working; stopping raises pressure again and speeds renal decline.

  • Does cell therapy lower blood pressure?

    That is not an indication and no evidence supports it; view it only as an inflammation-focused adjunct.

Medical cautions

5 points • reviewed 2026-09-02

Expand
  • This article is educational information only — not a diagnosis, prescription, or personal medical advice.
  • Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
  • Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
  • Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
  • Prices, packages, and service details can change — confirm directly with the provider before paying.

Reviewed and last updated: 2026-09-02

References and sources

5 sources • every claim is traceable

Expand
  1. 1. Original article on khunkim.com (pre-migration)

    https://www.ehlbio.co.kr

  2. 2. Korea Ministry of Food and Drug Safety (MFDS)

    https://www.mfds.go.kr/eng/index.do

  3. 3. Korea Ministry of Health and Welfare (MOHW)

    https://www.mohw.go.kr/eng/

  4. 4. PubMed medical research database (NIH)

    https://pubmed.ncbi.nlm.nih.gov/

  5. 5. Medical Korea — official info for international patients (KHIDI)

    https://www.medicalkorea.or.kr/

Browse the full reference library →

Share this page

Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories
Browse the stem cell library
See all in this category